reports
Abivax: 1 director
A director at Abivax sold 1,200,000 shares at 94.085EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
- Anis Zgaya
- Louis Boujard
- CFA
- Thomas Zlowodzki
TFI TELEVISION FRANCAISE 1 SA
SBS STRATEC SE
LSS LECTRA SA
ERA ERAMET SA
NANO NANOBIOTIX SA
ELIS ELIS SA
HEIJM HEIJMANS N.V. CERT
KOMN
CON KOMAX HOLDING AG
SSO CONZZETA AG
ROVI SCATEC ASA
DIC LABORATORIOS FARMACEUTICOS ROVI S.A.
MEL DIC ASSET AG
IBG MELIA HOTELS INTERNATIONAL S.A.
IDR IBERPAPEL GESTION S.A.
XFAB INDRA SISTEMAS S.A. CLASS A
DUFN X-FAB SILICON FOUNDRIES SE
CASH DUFRY AG
ALD PROSEGUR CASH SA
VOS ALD SA
2CRSI VOSSLOH AG
WAVE 2CRSI SA
GRP WAVESTONE SA
ZEL GREENCOAT RENEWABLES
TCH PHARMA MAR SA
TE TECHNICOLOR SA
ECMPA TECHNIP ENERGIES NV
FUR EUROCOMMERCIAL PROPERTIES NV
FLOW FUGRO NV
IOS FLOW TRADERS LTD
PLX IONOS GROUP SE
CO PLUXEE NV
VIRI CASINO GUICHARD-PERRACHON
VIRIDIEN
- Anis Zgaya
- Louis Boujard
- CFA
- Thomas Zlowodzki
TFI TELEVISION FRANCAISE 1 SA
SBS STRATEC SE
LSS LECTRA SA
ERA ERAMET SA
NANO NANOBIOTIX SA
ELIS ELIS SA
KOMN KOMAX HOLDING AG
CON CONZZETA AG
SSO SCATEC ASA
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
DIC DIC ASSET AG
MEL MELIA HOTELS INTERNATIONAL S.A.
IBG IBERPAPEL GESTION S.A.
IDR INDRA SISTEMAS S.A. CLASS A
XFAB X-FAB SILICON FOUNDRIES SE
DUFN DUFRY AG
CASH PROSEGUR CASH SA
ALD ALD SA
VOS VOSSLOH AG
2CRSI 2CRSI SA
WAVE WAVESTONE SA
GRP GREENCOAT RENEWABLES
ZEL PHARMA MAR SA
TCH TECHNICOLOR SA
TE TECHNIP ENERGIES NV
ECMPA EUROCOMMERCIAL PROPERTIES NV
FUR FUGRO NV
FLOW FLOW TRADERS LTD
IOS IONOS GROUP SE
PLX PLUXEE NV
CO CASINO GUICHARD-PERRACHON
VIRI VIRIDIEN
- Nicolas Thorez
- Nicolas Thorez
- Charlotte Vaisse
- Roy Külter
- Steven Boumans
MT ARCELORMITTAL SA
CLN CLARIANT AG
BEKB BEKAERT SA
SOP SOPRA STERIA GROUP SA
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
RCO REMY COINTREAU SA
INF INFOTEL SA
SZG SALZGITTER AG
WHA WERELDHAVE N.V.
AUB AUBAY SA
MTU MANITOU BF SA
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
EBRO EBRO FOODS SA
XIOR XIOR STUDENT HOUSING N.V.
G24 SCOUT24 AG
ERA ERAMET SA
COFB COFINIMMO SA
AIXA AIXTRON SE
NDA AURUBIS AG
ANA ACCIONA SA
VASTB VASTNED RETAIL BELGIUM NV
MONT MONTEA SCA
AED AEDIFICA SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
CPINV CARE PROPERTY INVEST SA
BRNL BRUNEL INTERNATIONAL N.V.
ONTEX ONTEX GROUP N.V.
SSO SCATEC ASA
LIGHT SIGNIFY NV
MELE MELEXIS NV
VGP VGP NV
CPS CYFROWY POLSAT SA
BOSN BOSSARD HOLDING AG
IDR INDRA SISTEMAS S.A. CLASS A
TRP TERAPLAST
RIO RIO TINTO PLC
DUFN DUFRY AG
BHP BHP GROUP LTD
ALD ALD SA
GALE GALENICA AG
BFSA BEFESA SA
AMAG AMAG AUSTRIA METALL AG
SANT S&T AG
NSI NSI N.V.
HFG HELLOFRESH SE
CLA CLARANOVA SE
WDP WAREHOUSES DE PAUW SCA
VUL VULCAN ENERGY RESOURCES
TE TECHNIP ENERGIES NV
ANE CORPORACION ACCIONA ENERGIAS RENOVABLES SA
ECMPA EUROCOMMERCIAL PROPERTIES NV
CTPNV CTP NV
BANB BACHEM HOLDING AG
FLOW FLOW TRADERS LTD
PLX PLUXEE NV
AAL ANGLO AMERICAN PLC
- Charlotte Vaisse
- Roy Külter
- Steven Boumans
MT ARCELORMITTAL SA
CLN CLARIANT AG
BEKB BEKAERT SA
SOP SOPRA STERIA GROUP SA
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
SSAB A SSAB AB CLASS A
RCO REMY COINTREAU SA
INF INFOTEL SA
SZG SALZGITTER AG
WHA WERELDHAVE N.V.
AUB AUBAY SA
MTU MANITOU BF SA
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
EBRO EBRO FOODS SA
XIOR XIOR STUDENT HOUSING N.V.
G24 SCOUT24 AG
ERA ERAMET SA
COFB COFINIMMO SA
AIXA AIXTRON SE
NDA AURUBIS AG
ANA ACCIONA SA
VASTB VASTNED RETAIL BELGIUM NV
MONT MONTEA SCA
AED AEDIFICA SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
CPINV CARE PROPERTY INVEST SA
BRNL BRUNEL INTERNATIONAL N.V.
ONTEX ONTEX GROUP N.V.
SSO SCATEC ASA
LIGHT SIGNIFY NV
MELE MELEXIS NV
VGP VGP NV
CPS CYFROWY POLSAT SA
BOSN BOSSARD HOLDING AG
IDR INDRA SISTEMAS S.A. CLASS A
TRP TERAPLAST
RIO RIO TINTO PLC
DUFN DUFRY AG
BHP BHP GROUP LTD
ALD ALD SA
GALE GALENICA AG
BFSA BEFESA SA
AMAG AMAG AUSTRIA METALL AG
SANT S&T AG
NSI NSI N.V.
HFG HELLOFRESH SE
CLA CLARANOVA SE
WDP WAREHOUSES DE PAUW SCA
VUL VULCAN ENERGY RESOURCES
TE TECHNIP ENERGIES NV
ANE CORPORACION ACCIONA ENERGIAS RENOVABLES SA
ECMPA EUROCOMMERCIAL PROPERTIES NV
CTPNV CTP NV
BANB BACHEM HOLDING AG
FLOW FLOW TRADERS LTD
PLX PLUXEE NV
AAL ANGLO AMERICAN PLC
- Nicolas Thorez
- Nicolas Thorez
ID Logistics: 1 director
A director at ID Logistics sold 1,017 shares at 405.050EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Emira Sagaama
- Emmanuel Matot
IPS IPSOS
FP TOTAL SE
PEO BANK POLSKA KASA OPIEKI SA
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
ORA ORANGE SA
SSAB A SSAB AB CLASS A
EN BOUYGUES SA
CEN GROUPE CRIT SA
IDL ID LOGISTICS GROUP
SDG SYNERGIE SA
ITP INTERPARFUMS
BLC BASTIDE LE CONFORT MEDICAL SA
PKO PKO BANK POLSKI S.A.
LPE LAURENT-PERRIER SA
GOE GROUPE GORGE SA
FNAC FNAC DARTY SA
ENI ENI S.P.A.
NEX NEXANS SA
ICAD ICADE SA
SPL SANTANDER BANK POLSKA SA
REP REPSOL SA
MIL BANK MILLENNIUM SA
VRNL VERNEUIL PARTICIPATIONS
ERG ERG S.P.A.
CTAC CTAC N.V.
TPS ORANGE POLSKA S.A.
AOF ATOSS SOFTWARE AG
RIEN RIETER HOLDING AG
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
CON CONZZETA AG
NVG NAVIGATOR COMPANY SA
INSD VERIMATRIX SA
ALR ALIOR BANK SA
VLTSA VOLTALIA
ECONT ECONOCOM GROUP SE CLASS D
BP. BP P.L.C.
GALE GALENICA AG
VRLA VERALLIA SAS
AZE AZELIS GROUP NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
4X0 STEYR MOTORS AG
- Jeremy Garnier
- Jeremy Garnier
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies 50 mg dose of once-daily obefazimod achieved clinically meaningful improvements, across all endpoints, regardless of prior inadequate response to advanced therapies (AT-IR) 50mg dose demonstrated clinically meaningful improvements in clinical remission in particip...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Res...
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data 50 mg once-daily dose of obefazimod led to a pooled 16.4% (p
- Ahmed Ben Salem
VAC PIERRE & VACANCES SA
BVB BORUSSIA DORTMUND GMBH & CO. KGAA
BON BONDUELLE SCA
NANO NANOBIOTIX SA
CFEB COMPAGNIE D'ENTREPRISES CFE SA
SIGHT GENSIGHT BIOLOGICS SA
VIG VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
DGM DIAGNOSTIC MEDICAL SYSTEMS
SPIE SPIE SA
HOME NEINOR HOMES SA
WAGA WAGA ENERGY SA
CTPNV CTP NV
LHYFE LHYFE S.A.
ORP ORPEA
4X0 STEYR MOTORS AG
HAVAS HAVAS N.V
- Ahmed Ben Salem
VAC PIERRE & VACANCES SA
BVB BORUSSIA DORTMUND GMBH & CO. KGAA
BON BONDUELLE SCA
NANO NANOBIOTIX SA
CFEB COMPAGNIE D'ENTREPRISES CFE SA
SIGHT GENSIGHT BIOLOGICS SA
VIG VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
DGM DIAGNOSTIC MEDICAL SYSTEMS
SPIE SPIE SA
HOME NEINOR HOMES SA
WAGA WAGA ENERGY SA
LHYFE LHYFE S.A.
ORP ORPEA
4X0 STEYR MOTORS AG
HAVAS HAVAS N.V
- Jean-François Granjon
- Jean-François Granjon
Abivax Announces Acceptance of Additional Late-Breaking Abstract from ...
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Abivax Announces Acceptance of AdditionalLate-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY AND SAFETY OF OBEFAZIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO, PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 8-WEEK INDUCTION TRIALS (ABTECT-1 & 2) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.